NCT06546137

Brief Summary

The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data. The main questions it aims to answer are: Which genes are most commonly affected? What is the frequency of these genetic alterations in our population? Participants will be interviewed in routine medical care visits and their DNA will be sequenced.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,211

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Apr 2025

Geographic Reach
1 country

27 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2025Aug 2026

First Submitted

Initial submission to the registry

August 6, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

April 30, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

May 8, 2026

Status Verified

November 1, 2025

Enrollment Period

1.3 years

First QC Date

August 6, 2024

Last Update Submit

May 4, 2026

Conditions

Keywords

hereditary cardiovascular diseaseswhole genome sequencing

Outcome Measures

Primary Outcomes (3)

  • Diagnostic yield

    Percentage of participants with pathogenic or likely pathogenic variants

    30 months after study start date

  • Genetic diversity

    Determine genes that cause hereditary cardiovascular diseases in Brazil

    30 months after study start date

  • Variant frequency

    Determine the frequency of disease-causing and benign variants in the Brazilian population

    30 months after study start date

Interventions

whole genome sequencing of genomic DNA extracted from buccal swab

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients under routine medical care in hospitals and clinics located in Brazil with a clinical diagnosis of an hereditary cardiovascular disease.

You may qualify if:

  • Clinical diagnosis of a hereditary cardiovascular disease according to current clinical guidelines
  • Agree to receive genetic counseling
  • Sign informed consent form
  • Provide the information required in the case report form

You may not qualify if:

  • Signature absent from informed consent form
  • Inadequate buccal swab (sample may be collected twice)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (27)

Centro de Pesquisa Silvestre Santé

Rio Branco, Acre, 69915-030, Brazil

RECRUITING

Centro de Pesquisas Clínicas Dr. Marco Mota

Maceió, Alagoas, 57051-160, Brazil

RECRUITING

Hospital Universitário da Unifap

Macapá, Amapá, 68903-419, Brazil

RECRUITING

Hospital de Messejana Dr. Carlos Alberto Studart Gomes

Fortaleza, Ceará, 60840-285, Brazil

RECRUITING

Hospital Evangélico de Vila Velha

Vila Velha, Espírito Santo, 29118-060, Brazil

RECRUITING

Hospital Universitário Professor Edgard Santos

Salvador, Estado de Bahia, 40110-060, Brazil

RECRUITING

Hospital Ana Nery - HAN/SESAB

Salvador, Estado de Bahia, 40320-010, Brazil

RECRUITING

Instituto de Cardiologia e Transplantes do Distrito Federal

Brasília, Federal District, 70675-731, Brazil

RECRUITING

Hospital das Clínicas da Universidade Federal de Goiás - HC-UFG

Goiânia, Goiás, 74605-050, Brazil

RECRUITING

Hospital Felicio Rocho - HFR

Belo Horizonte, Minas Gerais, 30110-934, Brazil

RECRUITING

Liga Mineira de Ressuscitação Cardiopulmonar

Belo Horizonte, Minas Gerais, 30130-110, Brazil

RECRUITING

Santa Casa de Misericórdia de Montes Claros

Montes Claros, Minas Gerais, 39401-001, Brazil

RECRUITING

Health & Care

Belém, Pará, 66093-055, Brazil

RECRUITING

Hospital Universitário Pedro Ernesto - UERJ

Rio de Janeiro, Rio de Janeiro, 20551-030, Brazil

RECRUITING

Instituto de Puericultura e Pediatria Martagão Gesteira

Rio de Janeiro, Rio de Janeiro, 21941-912, Brazil

RECRUITING

Hospital Universitário Clementino Fraga Filho - UFRJ

Rio de Janeiro, Rio de Janeiro, 21941-913, Brazil

RECRUITING

Instituto Nacional de Cardiologia

Rio de Janeiro, Rio de Janeiro, 22240-006, Brazil

RECRUITING

Hospital Universitário Onofre Lopes - UFRN

Natal, Rio Grande do Norte, 59012-300, Brazil

RECRUITING

Hospital das Clínicas de Porto Alegre - UFRGS

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

RECRUITING

Instituto de Cardiologia - Fundação Universitária de Cardiologia de Porto Alegre - IC-FUC

Porto Alegre, Rio Grande do Sul, 90040-370, Brazil

RECRUITING

Instituto de Pesquisa e Ensino em Saúde - IPES

Porto Velho, Rondônia, 76801-098, Brazil

RECRUITING

Centro Multidisciplinar de Ensino Especializado e Pesquisa Ltda

Joinville, Santa Catarina, 89204-250, Brazil

RECRUITING

Hospital Universitário São Francisco na Providência de Deus, USF-SP

Bragança Paulista, São Paulo, 12916-542, Brazil

RECRUITING

Instituto PENSI

Consolação, São Paulo, 01228-200, Brazil

RECRUITING

Hospital Universitário da Universidade Federal de São Carlos

São Carlos, São Paulo, 13566-448, Brazil

RECRUITING

Hospital do Coracao

São Paulo, São Paulo, 04004-030, Brazil

RECRUITING

Universidade Federal do Tocantins

Palmas, Tocantins, 77001-090, Brazil

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Saliva or cheek swabs

MeSH Terms

Conditions

Cardiomyopathy, HypertrophicCardiomyopathy, DilatedCardiomyopathy, RestrictiveArrhythmogenic Right Ventricular DysplasiaHyperlipoproteinemia Type IIMarfan SyndromeEhlers-Danlos Syndrome, Type IVLoeys-Dietz SyndromeLong QT SyndromeShort Qt SyndromeBrugada SyndromePolymorphic Catecholaminergic Ventricular TachycardiaDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesAortic Stenosis, SubvalvularAortic Valve StenosisAortic Valve DiseaseHeart Valve DiseasesCardiomegalyLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeart Defects, CongenitalCardiovascular AbnormalitiesCongenital AbnormalitiesLipid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsHyperlipoproteinemiasHyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesAbnormalities, MultipleConnective Tissue DiseasesSkin and Connective Tissue DiseasesAortic DissectionDissection, Blood VesselAneurysmVascular DiseasesEhlers-Danlos SyndromeHemostatic DisordersHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesSkin AbnormalitiesSkin Diseases, GeneticCollagen DiseasesSkin DiseasesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesAortic AneurysmAortic DiseasesArrhythmias, CardiacCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsTachycardia, VentricularTachycardiaHeart ArrestDeath, SuddenDeath

Central Study Contacts

Adriana Bastos Carvalho, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2024

First Posted

August 9, 2024

Study Start

April 30, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

May 8, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Genomic data are sensitve and will not be shared for individual participants

Locations